About Symbio
Built through chemistry.
Grown through partnerships.
Symbio was built by first-generation entrepreneurs with a clear ambition: stay close to customers, understand where the real gaps are, and steadily build the scientific and manufacturing capability to solve them.
Our journey
From an apartment in Bangalore
to an integrated manufacturing platform.
Building the scientific core.
Strengthening the science behind Symbio's next phase.
Small team. Long view.
The early years of building Symbio.
Early momentum.
Company beginning to take shape.
Growth gathered pace.
Another marker on the journey.
Into owned manufacturing.
VPL marked a defining shift.
Building the manufacturing platform.
Capability grew with the business.
Recognised along the way.
Independent industry recognition in 2022 & 2024.
Still building.
A larger team. The same entrepreneurial energy.
2011
Starting with the customer.
Symbio began with first-generation entrepreneurs working initially from an apartment in Bangalore. Early customer relationships and trading activity gave the team firsthand visibility into pharmaceutical supply gaps, with manufacturing always the longer-term ambition.
2017
Building the science.
A CMO partnership and a leased ~3,000 sq. ft. laboratory created Symbio's first dedicated R&D base and deeper technical ownership.
2021
Backed to build.
Ascent Capital partnered with Symbio, accelerating the company's shift towards a focused R&D and manufacturing platform.
2022
Building the manufacturing footprint.
Symbio acquired two manufacturing facilities, moving decisively from an asset-light model towards direct manufacturing ownership.
2024
Completing the core network.
A third manufacturing facility and the central Bangalore R&D Centre brought focused manufacturing and scientific development together within one network.
2026
Built for what's next.
Today, Symbio supplies 40+ molecules across 45+ countries through three manufacturing facilities supported by central R&D. The next chapter is focused on more complex molecules, specialised platforms and a selectively curated portfolio.
Our identity
Red has been part of the Symbio identity from the beginning.
At Symbio, red is more than a colour. It reflects the energy, optimism and conviction that have shaped the company from the beginning.
Symbio began by staying close to customers and building the capability to solve the problems they brought. Our red represents that journey: the fire to keep moving forward, the optimism to take on difficult problems and the discipline to build patiently for the long term.
The symmetry in our identity reflects the same principle. Progress is not created in isolation. Customers bring real problems, our scientists and manufacturing teams bring technical depth and execution, and partners, investors and communities shape the environment in which Symbio grows.
Each strengthens the other. As Symbio grows, red continues to represent both sides of our identity: the energy to pursue what is next and the precision to build it properly.
Where passion meets precision,
and relationships power progress.
Purpose
The work begins with chemistry.
Its purpose goes further.
Every route we improve and every molecule we manufacture sits upstream of a medicine someone may ultimately depend on.
That perspective keeps us focused on doing the fundamentals exceptionally well: robust science, consistent quality, dependable supply and responsible growth.
Learn more